nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—ADRA2A—epilepsy syndrome	0.306	1	CbGaD
Norepinephrine—SLC22A1—Midazolam—epilepsy syndrome	0.0523	0.244	CbGbCtD
Norepinephrine—SLC22A5—Valproic Acid—epilepsy syndrome	0.0479	0.223	CbGbCtD
Norepinephrine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0233	0.108	CbGbCtD
Norepinephrine—CYP1A2—Primidone—epilepsy syndrome	0.0217	0.101	CbGbCtD
Norepinephrine—CYP1A2—Propofol—epilepsy syndrome	0.0195	0.0906	CbGbCtD
Norepinephrine—CYP1A2—Phenobarbital—epilepsy syndrome	0.0186	0.0866	CbGbCtD
Norepinephrine—CYP1A2—Diazepam—epilepsy syndrome	0.0176	0.0821	CbGbCtD
Norepinephrine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0139	0.0647	CbGbCtD
Norepinephrine—Gangrene—Felbamate—epilepsy syndrome	0.00697	0.0436	CcSEcCtD
Norepinephrine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00532	0.0639	CbGeAlD
Norepinephrine—POU5F1—cerebellum—epilepsy syndrome	0.00466	0.0561	CbGeAlD
Norepinephrine—Gangrene—Pregabalin—epilepsy syndrome	0.00433	0.0271	CcSEcCtD
Norepinephrine—SLC18A2—telencephalic ventricle—epilepsy syndrome	0.00413	0.0497	CbGeAlD
Norepinephrine—Lactic acidosis—Pregabalin—epilepsy syndrome	0.00387	0.0242	CcSEcCtD
Norepinephrine—Retrosternal pain—Felbamate—epilepsy syndrome	0.00378	0.0236	CcSEcCtD
Norepinephrine—Hypovolaemia—Valproic Acid—epilepsy syndrome	0.00337	0.0211	CcSEcCtD
Norepinephrine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00282	0.034	CbGeAlD
Norepinephrine—Extravasation—Phenobarbital—epilepsy syndrome	0.00272	0.017	CcSEcCtD
Norepinephrine—Aggression—Rufinamide—epilepsy syndrome	0.00265	0.0166	CcSEcCtD
Norepinephrine—SLC18A2—ganglion—epilepsy syndrome	0.00257	0.0309	CbGeAlD
Norepinephrine—Photophobia—Trimethadione—epilepsy syndrome	0.00252	0.0157	CcSEcCtD
Norepinephrine—Aggression—Lacosamide—epilepsy syndrome	0.00249	0.0156	CcSEcCtD
Norepinephrine—Aggression—Clobazam—epilepsy syndrome	0.00242	0.0151	CcSEcCtD
Norepinephrine—Retrosternal pain—Pregabalin—epilepsy syndrome	0.00235	0.0147	CcSEcCtD
Norepinephrine—DRD2—telencephalic ventricle—epilepsy syndrome	0.0023	0.0276	CbGeAlD
Norepinephrine—Extravasation—Propofol—epilepsy syndrome	0.00201	0.0126	CcSEcCtD
Norepinephrine—Aggression—Midazolam—epilepsy syndrome	0.00196	0.0122	CcSEcCtD
Norepinephrine—SLC18A1—head—epilepsy syndrome	0.00193	0.0233	CbGeAlD
Norepinephrine—Aggression—Levetiracetam—epilepsy syndrome	0.00193	0.0121	CcSEcCtD
Norepinephrine—Pallor—Vigabatrin—epilepsy syndrome	0.00193	0.0121	CcSEcCtD
Norepinephrine—SLC22A1—ganglion—epilepsy syndrome	0.00192	0.023	CbGeAlD
Norepinephrine—Pallor—Diazepam—epilepsy syndrome	0.0019	0.0119	CcSEcCtD
Norepinephrine—SLC18A1—nervous system—epilepsy syndrome	0.00183	0.022	CbGeAlD
Norepinephrine—Aggression—Vigabatrin—epilepsy syndrome	0.00182	0.0114	CcSEcCtD
Norepinephrine—SLC22A3—tongue—epilepsy syndrome	0.00181	0.0218	CbGeAlD
Norepinephrine—Aggression—Diazepam—epilepsy syndrome	0.00179	0.0112	CcSEcCtD
Norepinephrine—SLC18A1—central nervous system—epilepsy syndrome	0.00176	0.0212	CbGeAlD
Norepinephrine—Aggression—Felbamate—epilepsy syndrome	0.00173	0.0108	CcSEcCtD
Norepinephrine—Aggression—Zonisamide—epilepsy syndrome	0.0017	0.0106	CcSEcCtD
Norepinephrine—Extravasation—Phenytoin—epilepsy syndrome	0.00163	0.0102	CcSEcCtD
Norepinephrine—Aggression—Clonazepam—epilepsy syndrome	0.00163	0.0102	CcSEcCtD
Norepinephrine—Bradycardia—Amobarbital—epilepsy syndrome	0.00162	0.0101	CcSEcCtD
Norepinephrine—Aggression—Oxcarbazepine—epilepsy syndrome	0.00161	0.0101	CcSEcCtD
Norepinephrine—SLC6A2—ganglion—epilepsy syndrome	0.00157	0.0189	CbGeAlD
Norepinephrine—Aggression—Carbamazepine—epilepsy syndrome	0.00155	0.00969	CcSEcCtD
Norepinephrine—Photophobia—Fosphenytoin—epilepsy syndrome	0.00154	0.00963	CcSEcCtD
Norepinephrine—DRD2—ganglion—epilepsy syndrome	0.00143	0.0172	CbGeAlD
Norepinephrine—SLC18A1—brain—epilepsy syndrome	0.0014	0.0169	CbGeAlD
Norepinephrine—Photophobia—Zonisamide—epilepsy syndrome	0.0014	0.00875	CcSEcCtD
Norepinephrine—PAH—head—epilepsy syndrome	0.00139	0.0167	CbGeAlD
Norepinephrine—Blood pressure increased—Carbamazepine—epilepsy syndrome	0.00136	0.00852	CcSEcCtD
Norepinephrine—Photophobia—Phenytoin—epilepsy syndrome	0.00134	0.00838	CcSEcCtD
Norepinephrine—Photophobia—Oxcarbazepine—epilepsy syndrome	0.00133	0.00833	CcSEcCtD
Norepinephrine—PAH—nervous system—epilepsy syndrome	0.00132	0.0158	CbGeAlD
Norepinephrine—PAH—central nervous system—epilepsy syndrome	0.00127	0.0152	CbGeAlD
Norepinephrine—Photophobia—Lamotrigine—epilepsy syndrome	0.00124	0.00773	CcSEcCtD
Norepinephrine—Bradycardia—Phenobarbital—epilepsy syndrome	0.00121	0.00759	CcSEcCtD
Norepinephrine—Aggression—Valproic Acid—epilepsy syndrome	0.00119	0.00744	CcSEcCtD
Norepinephrine—Anxiety—Amobarbital—epilepsy syndrome	0.00117	0.00734	CcSEcCtD
Norepinephrine—Pallor—Pregabalin—epilepsy syndrome	0.00114	0.00713	CcSEcCtD
Norepinephrine—Sweating—Clobazam—epilepsy syndrome	0.00114	0.00712	CcSEcCtD
Norepinephrine—Bradycardia—Lacosamide—epilepsy syndrome	0.00112	0.007	CcSEcCtD
Norepinephrine—SLC18A2—brainstem—epilepsy syndrome	0.00112	0.0134	CbGeAlD
Norepinephrine—ADRA1A—hindbrain—epilepsy syndrome	0.00111	0.0133	CbGeAlD
Norepinephrine—DRD2—hindbrain—epilepsy syndrome	0.00108	0.013	CbGeAlD
Norepinephrine—SLC18A2—forebrain—epilepsy syndrome	0.00108	0.013	CbGeAlD
Norepinephrine—Aggression—Pregabalin—epilepsy syndrome	0.00108	0.00673	CcSEcCtD
Norepinephrine—ADRA1D—forebrain—epilepsy syndrome	0.00107	0.0128	CbGeAlD
Norepinephrine—PAH—brain—epilepsy syndrome	0.00101	0.0121	CbGeAlD
Norepinephrine—SLC18A2—telencephalon—epilepsy syndrome	0.000992	0.0119	CbGeAlD
Norepinephrine—Photophobia—Valproic Acid—epilepsy syndrome	0.000981	0.00614	CcSEcCtD
Norepinephrine—ADRA1D—telencephalon—epilepsy syndrome	0.00098	0.0118	CbGeAlD
Norepinephrine—Bradycardia—Propofol—epilepsy syndrome	0.000898	0.00562	CcSEcCtD
Norepinephrine—Photophobia—Pregabalin—epilepsy syndrome	0.000887	0.00555	CcSEcCtD
Norepinephrine—Anxiety—Phenobarbital—epilepsy syndrome	0.00088	0.00551	CcSEcCtD
Norepinephrine—Pallor—Topiramate—epilepsy syndrome	0.000879	0.0055	CcSEcCtD
Norepinephrine—Bradycardia—Midazolam—epilepsy syndrome	0.000879	0.0055	CcSEcCtD
Norepinephrine—Sweating—Fosphenytoin—epilepsy syndrome	0.000879	0.0055	CcSEcCtD
Norepinephrine—Blood pressure increased—Gabapentin—epilepsy syndrome	0.000867	0.00542	CcSEcCtD
Norepinephrine—Anxiety—Rufinamide—epilepsy syndrome	0.000864	0.00541	CcSEcCtD
Norepinephrine—Sweating—Diazepam—epilepsy syndrome	0.000843	0.00528	CcSEcCtD
Norepinephrine—Bradycardia—Fosphenytoin—epilepsy syndrome	0.000838	0.00524	CcSEcCtD
Norepinephrine—Aggression—Topiramate—epilepsy syndrome	0.00083	0.00519	CcSEcCtD
Norepinephrine—Sweating—Felbamate—epilepsy syndrome	0.000816	0.00511	CcSEcCtD
Norepinephrine—Chest pain—Lacosamide—epilepsy syndrome	0.000814	0.00509	CcSEcCtD
Norepinephrine—Photophobia—Gabapentin—epilepsy syndrome	0.000814	0.00509	CcSEcCtD
Norepinephrine—SLC22A1—forebrain—epilepsy syndrome	0.000804	0.00967	CbGeAlD
Norepinephrine—Bradycardia—Diazepam—epilepsy syndrome	0.000804	0.00503	CcSEcCtD
Norepinephrine—Sweating—Zonisamide—epilepsy syndrome	0.000799	0.005	CcSEcCtD
Norepinephrine—Arrhythmia—Propofol—epilepsy syndrome	0.000788	0.00493	CcSEcCtD
Norepinephrine—Anxiety—Clobazam—epilepsy syndrome	0.000787	0.00493	CcSEcCtD
Norepinephrine—SLC18A2—medulla oblongata—epilepsy syndrome	0.000779	0.00937	CbGeAlD
Norepinephrine—Bradycardia—Felbamate—epilepsy syndrome	0.000778	0.00487	CcSEcCtD
Norepinephrine—ADRB1—forebrain—epilepsy syndrome	0.000774	0.00931	CbGeAlD
Norepinephrine—Sweating—Phenytoin—epilepsy syndrome	0.000765	0.00479	CcSEcCtD
Norepinephrine—Bradycardia—Zonisamide—epilepsy syndrome	0.000761	0.00477	CcSEcCtD
Norepinephrine—Hyperhidrosis—Lacosamide—epilepsy syndrome	0.000754	0.00472	CcSEcCtD
Norepinephrine—SLC22A1—telencephalon—epilepsy syndrome	0.000739	0.00889	CbGeAlD
Norepinephrine—Hyperhidrosis—Clobazam—epilepsy syndrome	0.000732	0.00458	CcSEcCtD
Norepinephrine—Bradycardia—Phenytoin—epilepsy syndrome	0.000729	0.00456	CcSEcCtD
Norepinephrine—Bradycardia—Oxcarbazepine—epilepsy syndrome	0.000725	0.00454	CcSEcCtD
Norepinephrine—Vomiting—Amobarbital—epilepsy syndrome	0.000717	0.00449	CcSEcCtD
Norepinephrine—SLC18A2—midbrain—epilepsy syndrome	0.000712	0.00857	CbGeAlD
Norepinephrine—ADRB1—telencephalon—epilepsy syndrome	0.000712	0.00856	CbGeAlD
Norepinephrine—Headache—Amobarbital—epilepsy syndrome	0.000707	0.00442	CcSEcCtD
Norepinephrine—Sweating—Lamotrigine—epilepsy syndrome	0.000705	0.00441	CcSEcCtD
Norepinephrine—Arrhythmia—Diazepam—epilepsy syndrome	0.000705	0.00441	CcSEcCtD
Norepinephrine—Bradycardia—Carbamazepine—epilepsy syndrome	0.000696	0.00435	CcSEcCtD
Norepinephrine—Vomiting—Primidone—epilepsy syndrome	0.000691	0.00432	CcSEcCtD
Norepinephrine—Photophobia—Topiramate—epilepsy syndrome	0.000684	0.00428	CcSEcCtD
Norepinephrine—SLC6A2—brainstem—epilepsy syndrome	0.000682	0.0082	CbGeAlD
Norepinephrine—Headache—Primidone—epilepsy syndrome	0.000681	0.00426	CcSEcCtD
Norepinephrine—Hypertension—Propofol—epilepsy syndrome	0.000663	0.00415	CcSEcCtD
Norepinephrine—SLC6A2—forebrain—epilepsy syndrome	0.000658	0.00792	CbGeAlD
Norepinephrine—Chest pain—Propofol—epilepsy syndrome	0.000654	0.00409	CcSEcCtD
Norepinephrine—Anxiety—Propofol—epilepsy syndrome	0.000652	0.00408	CcSEcCtD
Norepinephrine—Anxiety—Midazolam—epilepsy syndrome	0.000638	0.00399	CcSEcCtD
Norepinephrine—Arrhythmia—Oxcarbazepine—epilepsy syndrome	0.000636	0.00398	CcSEcCtD
Norepinephrine—ADRA1A—brainstem—epilepsy syndrome	0.000634	0.00763	CbGeAlD
Norepinephrine—Chest pain—Levetiracetam—epilepsy syndrome	0.000632	0.00395	CcSEcCtD
Norepinephrine—Anxiety—Levetiracetam—epilepsy syndrome	0.00063	0.00394	CcSEcCtD
Norepinephrine—ADRA1B—head—epilepsy syndrome	0.000624	0.0075	CbGeAlD
Norepinephrine—DRD2—brainstem—epilepsy syndrome	0.000622	0.00748	CbGeAlD
Norepinephrine—Hypertension—Fosphenytoin—epilepsy syndrome	0.000618	0.00387	CcSEcCtD
Norepinephrine—SLC18A2—head—epilepsy syndrome	0.000618	0.00743	CbGeAlD
Norepinephrine—ADRA1A—forebrain—epilepsy syndrome	0.000612	0.00736	CbGeAlD
Norepinephrine—Arrhythmia—Carbamazepine—epilepsy syndrome	0.000611	0.00382	CcSEcCtD
Norepinephrine—ADRA1D—head—epilepsy syndrome	0.00061	0.00734	CbGeAlD
Norepinephrine—Vomiting—Trimethadione—epilepsy syndrome	0.000608	0.0038	CcSEcCtD
Norepinephrine—Hyperhidrosis—Propofol—epilepsy syndrome	0.000606	0.00379	CcSEcCtD
Norepinephrine—SLC6A2—telencephalon—epilepsy syndrome	0.000605	0.00728	CbGeAlD
Norepinephrine—DRD2—forebrain—epilepsy syndrome	0.0006	0.00721	CbGeAlD
Norepinephrine—Headache—Trimethadione—epilepsy syndrome	0.000599	0.00375	CcSEcCtD
Norepinephrine—Methyldopa—ADRA2A—epilepsy syndrome	0.000598	0.189	CrCbGaD
Norepinephrine—Chest pain—Vigabatrin—epilepsy syndrome	0.000594	0.00372	CcSEcCtD
Norepinephrine—Anxiety—Vigabatrin—epilepsy syndrome	0.000592	0.00371	CcSEcCtD
Norepinephrine—ADRA1B—nervous system—epilepsy syndrome	0.000591	0.00711	CbGeAlD
Norepinephrine—SLC18A2—nervous system—epilepsy syndrome	0.000586	0.00704	CbGeAlD
Norepinephrine—ADRA1D—nervous system—epilepsy syndrome	0.000578	0.00696	CbGeAlD
Norepinephrine—Hypertension—Felbamate—epilepsy syndrome	0.000574	0.00359	CcSEcCtD
Norepinephrine—ADRA1B—central nervous system—epilepsy syndrome	0.000569	0.00685	CbGeAlD
Norepinephrine—Chest pain—Felbamate—epilepsy syndrome	0.000566	0.00354	CcSEcCtD
Norepinephrine—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000565	0.00354	CcSEcCtD
Norepinephrine—Anxiety—Felbamate—epilepsy syndrome	0.000564	0.00353	CcSEcCtD
Norepinephrine—SLC18A2—central nervous system—epilepsy syndrome	0.000564	0.00678	CbGeAlD
Norepinephrine—ADRA1A—telencephalon—epilepsy syndrome	0.000563	0.00677	CbGeAlD
Norepinephrine—Hypertension—Zonisamide—epilepsy syndrome	0.000562	0.00352	CcSEcCtD
Norepinephrine—Sweating—Valproic Acid—epilepsy syndrome	0.000561	0.00351	CcSEcCtD
Norepinephrine—Dyspnoea—Propofol—epilepsy syndrome	0.000559	0.0035	CcSEcCtD
Norepinephrine—ADRA1D—central nervous system—epilepsy syndrome	0.000557	0.0067	CbGeAlD
Norepinephrine—Chest pain—Zonisamide—epilepsy syndrome	0.000554	0.00347	CcSEcCtD
Norepinephrine—Anxiety—Zonisamide—epilepsy syndrome	0.000552	0.00346	CcSEcCtD
Norepinephrine—DRD2—telencephalon—epilepsy syndrome	0.000552	0.00663	CbGeAlD
Norepinephrine—SLC18A2—cerebellum—epilepsy syndrome	0.000551	0.00663	CbGeAlD
Norepinephrine—Dyspnoea—Midazolam—epilepsy syndrome	0.000547	0.00342	CcSEcCtD
Norepinephrine—Hyperhidrosis—Diazepam—epilepsy syndrome	0.000542	0.00339	CcSEcCtD
Norepinephrine—Vomiting—Phenobarbital—epilepsy syndrome	0.000538	0.00337	CcSEcCtD
Norepinephrine—Hypertension—Phenytoin—epilepsy syndrome	0.000538	0.00337	CcSEcCtD
Norepinephrine—ADRA2C—telencephalon—epilepsy syndrome	0.000536	0.00645	CbGeAlD
Norepinephrine—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000535	0.00335	CcSEcCtD
Norepinephrine—Bradycardia—Valproic Acid—epilepsy syndrome	0.000534	0.00334	CcSEcCtD
Norepinephrine—Chest pain—Clonazepam—epilepsy syndrome	0.000534	0.00334	CcSEcCtD
Norepinephrine—Anxiety—Clonazepam—epilepsy syndrome	0.000532	0.00333	CcSEcCtD
Norepinephrine—Chest pain—Phenytoin—epilepsy syndrome	0.000531	0.00332	CcSEcCtD
Norepinephrine—Headache—Phenobarbital—epilepsy syndrome	0.00053	0.00332	CcSEcCtD
Norepinephrine—Levonordefrin—ADRA2A—epilepsy syndrome	0.00053	0.168	CrCbGaD
Norepinephrine—Vomiting—Rufinamide—epilepsy syndrome	0.000528	0.00331	CcSEcCtD
Norepinephrine—Chest pain—Oxcarbazepine—epilepsy syndrome	0.000528	0.0033	CcSEcCtD
Norepinephrine—Anxiety—Oxcarbazepine—epilepsy syndrome	0.000526	0.00329	CcSEcCtD
Norepinephrine—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000525	0.00328	CcSEcCtD
Norepinephrine—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000521	0.00326	CcSEcCtD
Norepinephrine—Headache—Rufinamide—epilepsy syndrome	0.000521	0.00326	CcSEcCtD
Norepinephrine—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000514	0.00321	CcSEcCtD
Norepinephrine—Hypertension—Carbamazepine—epilepsy syndrome	0.000514	0.00321	CcSEcCtD
Norepinephrine—Sweating—Pregabalin—epilepsy syndrome	0.000507	0.00317	CcSEcCtD
Norepinephrine—Chest pain—Carbamazepine—epilepsy syndrome	0.000507	0.00317	CcSEcCtD
Norepinephrine—Anxiety—Carbamazepine—epilepsy syndrome	0.000505	0.00316	CcSEcCtD
Norepinephrine—Dyspnoea—Diazepam—epilepsy syndrome	0.0005	0.00313	CcSEcCtD
Norepinephrine—Hypertension—Lamotrigine—epilepsy syndrome	0.000496	0.00311	CcSEcCtD
Norepinephrine—Vomiting—Lacosamide—epilepsy syndrome	0.000496	0.0031	CcSEcCtD
Norepinephrine—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000492	0.00308	CcSEcCtD
Norepinephrine—Chest pain—Lamotrigine—epilepsy syndrome	0.00049	0.00306	CcSEcCtD
Norepinephrine—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000489	0.00306	CcSEcCtD
Norepinephrine—Headache—Lacosamide—epilepsy syndrome	0.000489	0.00306	CcSEcCtD
Norepinephrine—Anxiety—Lamotrigine—epilepsy syndrome	0.000488	0.00305	CcSEcCtD
Norepinephrine—Dyspnoea—Felbamate—epilepsy syndrome	0.000484	0.00303	CcSEcCtD
Norepinephrine—Bradycardia—Pregabalin—epilepsy syndrome	0.000483	0.00302	CcSEcCtD
Norepinephrine—Vomiting—Clobazam—epilepsy syndrome	0.000481	0.00301	CcSEcCtD
Norepinephrine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000476	0.00572	CbGeAlD
Norepinephrine—Headache—Clobazam—epilepsy syndrome	0.000474	0.00297	CcSEcCtD
Norepinephrine—Dyspnoea—Zonisamide—epilepsy syndrome	0.000474	0.00296	CcSEcCtD
Norepinephrine—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000469	0.00294	CcSEcCtD
Norepinephrine—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000469	0.00293	CcSEcCtD
Norepinephrine—ADRA2A—forebrain—epilepsy syndrome	0.000465	0.0056	CbGeAlD
Norepinephrine—Sweating—Gabapentin—epilepsy syndrome	0.000465	0.00291	CcSEcCtD
Norepinephrine—SLC22A1—head—epilepsy syndrome	0.00046	0.00554	CbGeAlD
Norepinephrine—Dyspnoea—Clonazepam—epilepsy syndrome	0.000457	0.00286	CcSEcCtD
Norepinephrine—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000454	0.00284	CcSEcCtD
Norepinephrine—Dyspnoea—Phenytoin—epilepsy syndrome	0.000454	0.00284	CcSEcCtD
Norepinephrine—ADRA1B—brain—epilepsy syndrome	0.000452	0.00544	CbGeAlD
Norepinephrine—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000451	0.00282	CcSEcCtD
Norepinephrine—SLC18A2—brain—epilepsy syndrome	0.000448	0.00538	CbGeAlD
Norepinephrine—ADRB1—head—epilepsy syndrome	0.000443	0.00533	CbGeAlD
Norepinephrine—Bradycardia—Gabapentin—epilepsy syndrome	0.000443	0.00277	CcSEcCtD
Norepinephrine—ADRA1D—brain—epilepsy syndrome	0.000442	0.00532	CbGeAlD
Norepinephrine—SLC22A3—head—epilepsy syndrome	0.00044	0.00529	CbGeAlD
Norepinephrine—SLC22A1—nervous system—epilepsy syndrome	0.000436	0.00525	CbGeAlD
Norepinephrine—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000433	0.00271	CcSEcCtD
Norepinephrine—Vomiting—Acetazolamide—epilepsy syndrome	0.000429	0.00269	CcSEcCtD
Norepinephrine—ADRA2A—telencephalon—epilepsy syndrome	0.000428	0.00515	CbGeAlD
Norepinephrine—Arrhythmia—Pregabalin—epilepsy syndrome	0.000424	0.00265	CcSEcCtD
Norepinephrine—Headache—Acetazolamide—epilepsy syndrome	0.000423	0.00265	CcSEcCtD
Norepinephrine—ADRA2C—medulla oblongata—epilepsy syndrome	0.000421	0.00507	CbGeAlD
Norepinephrine—ADRB1—nervous system—epilepsy syndrome	0.00042	0.00505	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—epilepsy syndrome	0.00042	0.00505	CbGeAlD
Norepinephrine—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000418	0.00262	CcSEcCtD
Norepinephrine—SLC22A3—nervous system—epilepsy syndrome	0.000417	0.00502	CbGeAlD
Norepinephrine—ADRB1—central nervous system—epilepsy syndrome	0.000405	0.00487	CbGeAlD
Norepinephrine—SLC22A5—medulla oblongata—epilepsy syndrome	0.000404	0.00485	CbGeAlD
Norepinephrine—SLC22A3—central nervous system—epilepsy syndrome	0.000402	0.00483	CbGeAlD
Norepinephrine—Vomiting—Propofol—epilepsy syndrome	0.000399	0.00249	CcSEcCtD
Norepinephrine—DRD2—midbrain—epilepsy syndrome	0.000396	0.00476	CbGeAlD
Norepinephrine—Hypertension—Valproic Acid—epilepsy syndrome	0.000395	0.00247	CcSEcCtD
Norepinephrine—Headache—Propofol—epilepsy syndrome	0.000393	0.00246	CcSEcCtD
Norepinephrine—Vomiting—Midazolam—epilepsy syndrome	0.00039	0.00244	CcSEcCtD
Norepinephrine—Chest pain—Valproic Acid—epilepsy syndrome	0.000389	0.00243	CcSEcCtD
Norepinephrine—Anxiety—Valproic Acid—epilepsy syndrome	0.000388	0.00243	CcSEcCtD
Norepinephrine—ADRA2C—midbrain—epilepsy syndrome	0.000385	0.00463	CbGeAlD
Norepinephrine—Vomiting—Levetiracetam—epilepsy syndrome	0.000385	0.00241	CcSEcCtD
Norepinephrine—Headache—Midazolam—epilepsy syndrome	0.000384	0.0024	CcSEcCtD
Norepinephrine—Headache—Levetiracetam—epilepsy syndrome	0.000379	0.00237	CcSEcCtD
Norepinephrine—SLC6A2—head—epilepsy syndrome	0.000377	0.00453	CbGeAlD
Norepinephrine—ADRA2C—spinal cord—epilepsy syndrome	0.000376	0.00452	CbGeAlD
Norepinephrine—Droxidopa—ADRA2A—epilepsy syndrome	0.000373	0.118	CrCbGaD
Norepinephrine—Bradycardia—Topiramate—epilepsy syndrome	0.000373	0.00233	CcSEcCtD
Norepinephrine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000372	0.00233	CcSEcCtD
Norepinephrine—SLC22A5—midbrain—epilepsy syndrome	0.000369	0.00444	CbGeAlD
Norepinephrine—Headache—Fosphenytoin—epilepsy syndrome	0.000366	0.00229	CcSEcCtD
Norepinephrine—Vomiting—Vigabatrin—epilepsy syndrome	0.000362	0.00227	CcSEcCtD
Norepinephrine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000361	0.00226	CcSEcCtD
Norepinephrine—SLC22A5—spinal cord—epilepsy syndrome	0.00036	0.00433	CbGeAlD
Norepinephrine—SLC6A2—nervous system—epilepsy syndrome	0.000357	0.0043	CbGeAlD
Norepinephrine—Headache—Vigabatrin—epilepsy syndrome	0.000357	0.00223	CcSEcCtD
Norepinephrine—Hypertension—Pregabalin—epilepsy syndrome	0.000357	0.00223	CcSEcCtD
Norepinephrine—Vomiting—Diazepam—epilepsy syndrome	0.000357	0.00223	CcSEcCtD
Norepinephrine—Chest pain—Pregabalin—epilepsy syndrome	0.000352	0.0022	CcSEcCtD
Norepinephrine—Headache—Diazepam—epilepsy syndrome	0.000351	0.0022	CcSEcCtD
Norepinephrine—Anxiety—Pregabalin—epilepsy syndrome	0.00035	0.00219	CcSEcCtD
Norepinephrine—ADRA1A—head—epilepsy syndrome	0.00035	0.00421	CbGeAlD
Norepinephrine—Vomiting—Felbamate—epilepsy syndrome	0.000345	0.00216	CcSEcCtD
Norepinephrine—SLC6A2—central nervous system—epilepsy syndrome	0.000344	0.00414	CbGeAlD
Norepinephrine—DRD2—head—epilepsy syndrome	0.000343	0.00413	CbGeAlD
Norepinephrine—Dopamine—HTR7—epilepsy syndrome	0.000341	0.108	CrCbGaD
Norepinephrine—Headache—Felbamate—epilepsy syndrome	0.00034	0.00213	CcSEcCtD
Norepinephrine—Vomiting—Zonisamide—epilepsy syndrome	0.000338	0.00211	CcSEcCtD
Norepinephrine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000336	0.00404	CbGeAlD
Norepinephrine—ADRA2C—head—epilepsy syndrome	0.000334	0.00402	CbGeAlD
Norepinephrine—SLC22A1—brain—epilepsy syndrome	0.000334	0.00401	CbGeAlD
Norepinephrine—Headache—Zonisamide—epilepsy syndrome	0.000333	0.00208	CcSEcCtD
Norepinephrine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000332	0.00208	CcSEcCtD
Norepinephrine—ADRA1A—nervous system—epilepsy syndrome	0.000332	0.004	CbGeAlD
Norepinephrine—Hypertension—Gabapentin—epilepsy syndrome	0.000327	0.00205	CcSEcCtD
Norepinephrine—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000326	0.00204	CcSEcCtD
Norepinephrine—DRD2—nervous system—epilepsy syndrome	0.000326	0.00392	CbGeAlD
Norepinephrine—Vomiting—Clonazepam—epilepsy syndrome	0.000326	0.00204	CcSEcCtD
Norepinephrine—Vomiting—Phenytoin—epilepsy syndrome	0.000323	0.00202	CcSEcCtD
Norepinephrine—Chest pain—Gabapentin—epilepsy syndrome	0.000323	0.00202	CcSEcCtD
Norepinephrine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000322	0.00201	CcSEcCtD
Norepinephrine—Anxiety—Gabapentin—epilepsy syndrome	0.000321	0.00201	CcSEcCtD
Norepinephrine—ADRB1—brain—epilepsy syndrome	0.000321	0.00386	CbGeAlD
Norepinephrine—Headache—Clonazepam—epilepsy syndrome	0.000321	0.00201	CcSEcCtD
Norepinephrine—ADRA1A—central nervous system—epilepsy syndrome	0.00032	0.00385	CbGeAlD
Norepinephrine—SLC22A3—brain—epilepsy syndrome	0.000319	0.00383	CbGeAlD
Norepinephrine—Headache—Phenytoin—epilepsy syndrome	0.000319	0.00199	CcSEcCtD
Norepinephrine—Headache—Oxcarbazepine—epilepsy syndrome	0.000317	0.00198	CcSEcCtD
Norepinephrine—ADRA2C—nervous system—epilepsy syndrome	0.000317	0.00381	CbGeAlD
Norepinephrine—DRD2—central nervous system—epilepsy syndrome	0.000314	0.00377	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—epilepsy syndrome	0.000313	0.00376	CbGeAlD
Norepinephrine—Vomiting—Carbamazepine—epilepsy syndrome	0.000309	0.00193	CcSEcCtD
Norepinephrine—ADRA2A—midbrain—epilepsy syndrome	0.000307	0.0037	CbGeAlD
Norepinephrine—DRD2—cerebellum—epilepsy syndrome	0.000306	0.00369	CbGeAlD
Norepinephrine—ADRA2C—central nervous system—epilepsy syndrome	0.000305	0.00367	CbGeAlD
Norepinephrine—Headache—Carbamazepine—epilepsy syndrome	0.000304	0.0019	CcSEcCtD
Norepinephrine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000301	0.00188	CcSEcCtD
Norepinephrine—ADRA2A—spinal cord—epilepsy syndrome	0.0003	0.00361	CbGeAlD
Norepinephrine—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000299	0.00187	CcSEcCtD
Norepinephrine—Vomiting—Lamotrigine—epilepsy syndrome	0.000298	0.00187	CcSEcCtD
Norepinephrine—ADRA2C—cerebellum—epilepsy syndrome	0.000298	0.00358	CbGeAlD
Norepinephrine—Headache—Lamotrigine—epilepsy syndrome	0.000294	0.00184	CcSEcCtD
Norepinephrine—SLC22A5—cerebellum—epilepsy syndrome	0.000285	0.00343	CbGeAlD
Norepinephrine—Epinephrine—ADRA2A—epilepsy syndrome	0.000285	0.0903	CrCbGaD
Norepinephrine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000276	0.00172	CcSEcCtD
Norepinephrine—Hypertension—Topiramate—epilepsy syndrome	0.000275	0.00172	CcSEcCtD
Norepinephrine—SLC6A2—brain—epilepsy syndrome	0.000273	0.00329	CbGeAlD
Norepinephrine—Chest pain—Topiramate—epilepsy syndrome	0.000271	0.0017	CcSEcCtD
Norepinephrine—Anxiety—Topiramate—epilepsy syndrome	0.00027	0.00169	CcSEcCtD
Norepinephrine—Epinephrine—TNF—epilepsy syndrome	0.00027	0.0856	CrCbGaD
Norepinephrine—ADRA2A—head—epilepsy syndrome	0.000266	0.0032	CbGeAlD
Norepinephrine—ADRA1A—brain—epilepsy syndrome	0.000254	0.00305	CbGeAlD
Norepinephrine—ADRA2A—nervous system—epilepsy syndrome	0.000253	0.00304	CbGeAlD
Norepinephrine—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000251	0.00157	CcSEcCtD
Norepinephrine—DRD2—brain—epilepsy syndrome	0.000249	0.00299	CbGeAlD
Norepinephrine—ADRA2A—central nervous system—epilepsy syndrome	0.000243	0.00293	CbGeAlD
Norepinephrine—ADRA2C—brain—epilepsy syndrome	0.000242	0.00291	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—epilepsy syndrome	0.000238	0.00286	CbGeAlD
Norepinephrine—Vomiting—Valproic Acid—epilepsy syndrome	0.000237	0.00148	CcSEcCtD
Norepinephrine—Headache—Valproic Acid—epilepsy syndrome	0.000234	0.00146	CcSEcCtD
Norepinephrine—Dyspnoea—Topiramate—epilepsy syndrome	0.000232	0.00145	CcSEcCtD
Norepinephrine—SLC22A5—brain—epilepsy syndrome	0.000232	0.00279	CbGeAlD
Norepinephrine—Dopamine—SLC6A4—epilepsy syndrome	0.000223	0.0706	CrCbGaD
Norepinephrine—Vomiting—Pregabalin—epilepsy syndrome	0.000214	0.00134	CcSEcCtD
Norepinephrine—Headache—Pregabalin—epilepsy syndrome	0.000211	0.00132	CcSEcCtD
Norepinephrine—Dopamine—CYP2C19—epilepsy syndrome	0.000211	0.0669	CrCbGaD
Norepinephrine—Vomiting—Gabapentin—epilepsy syndrome	0.000197	0.00123	CcSEcCtD
Norepinephrine—Headache—Gabapentin—epilepsy syndrome	0.000194	0.00121	CcSEcCtD
Norepinephrine—ADRA2A—brain—epilepsy syndrome	0.000193	0.00232	CbGeAlD
Norepinephrine—L-DOPA—CYP2D6—epilepsy syndrome	0.000168	0.0534	CrCbGaD
Norepinephrine—Vomiting—Topiramate—epilepsy syndrome	0.000165	0.00103	CcSEcCtD
Norepinephrine—Headache—Topiramate—epilepsy syndrome	0.000163	0.00102	CcSEcCtD
Norepinephrine—Dopamine—CYP2D6—epilepsy syndrome	0.000157	0.0496	CrCbGaD
Norepinephrine—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	3.13e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	3.11e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	3.1e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	3.1e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	3.09e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	3.07e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	3.07e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	3.06e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	3.06e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	3.05e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	3.05e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	3.04e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	3.03e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	3.03e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	3.02e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	3.01e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	3.01e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	3.01e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	3e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	3e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.99e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	2.99e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	2.99e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	2.99e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	2.98e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	2.97e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	2.95e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	2.95e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	2.95e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	2.94e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—POMC—epilepsy syndrome	2.94e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	2.92e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	2.92e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.92e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.9e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	2.89e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.89e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.88e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	2.88e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.88e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.88e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—POMC—epilepsy syndrome	2.86e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	2.85e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	2.84e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	2.84e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	2.84e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	2.84e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	2.83e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	2.83e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	2.81e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	2.81e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	2.8e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	2.8e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	2.8e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	2.78e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.78e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.78e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	2.77e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	2.77e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	2.76e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	2.76e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AGT—epilepsy syndrome	2.76e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	2.75e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—POMC—epilepsy syndrome	2.74e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	2.74e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	2.74e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	2.73e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.72e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—epilepsy syndrome	2.7e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	2.69e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	2.68e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ALB—epilepsy syndrome	2.68e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.68e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	2.68e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.67e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	2.63e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.63e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.62e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.62e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	2.61e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—epilepsy syndrome	2.61e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.58e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	2.58e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.58e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.58e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.58e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.57e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	2.56e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	2.56e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	2.53e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	2.53e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.53e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	2.51e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	2.51e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.5e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.49e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	2.49e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.49e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	2.48e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.48e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.47e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	2.47e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	2.43e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	2.43e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	2.39e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	2.38e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.38e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.37e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.37e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	2.35e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	2.35e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.34e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	2.34e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.33e-06	1e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	2.33e-06	1e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—POMC—epilepsy syndrome	2.32e-06	9.98e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	2.31e-06	9.93e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	2.31e-06	9.91e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	2.3e-06	9.89e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	2.3e-06	9.87e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.3e-06	9.87e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.3e-06	9.86e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.29e-06	9.82e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	2.28e-06	9.81e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	2.28e-06	9.81e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	2.28e-06	9.8e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	2.26e-06	9.73e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	2.26e-06	9.71e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	2.24e-06	9.6e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	2.22e-06	9.52e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	2.19e-06	9.39e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.17e-06	9.32e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.13e-06	9.16e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.12e-06	9.12e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.12e-06	9.12e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	2.12e-06	9.11e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.12e-06	9.1e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—epilepsy syndrome	2.12e-06	9.1e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	2.11e-06	9.08e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	2.1e-06	9.03e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	2.1e-06	9.02e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	2.09e-06	8.98e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	2.08e-06	8.94e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	2.08e-06	8.93e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	2.07e-06	8.91e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	2.06e-06	8.85e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	2.05e-06	8.79e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	2.04e-06	8.76e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	2.03e-06	8.74e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.98e-06	8.52e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1.96e-06	8.43e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.95e-06	8.36e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.94e-06	8.34e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.93e-06	8.3e-06	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.93e-06	8.29e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	1.93e-06	8.27e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.92e-06	8.27e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.92e-06	8.25e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.92e-06	8.24e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.91e-06	8.22e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	1.91e-06	8.22e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.9e-06	8.16e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.9e-06	8.14e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.89e-06	8.14e-06	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.89e-06	8.11e-06	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—epilepsy syndrome	1.88e-06	8.07e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	1.87e-06	8.04e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.87e-06	8.03e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	1.86e-06	7.98e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.85e-06	7.96e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.85e-06	7.94e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.84e-06	7.91e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.83e-06	7.86e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	1.82e-06	7.81e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	1.81e-06	7.77e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.79e-06	7.7e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.79e-06	7.68e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.78e-06	7.65e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.78e-06	7.65e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	1.77e-06	7.61e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	1.77e-06	7.6e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.76e-06	7.56e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	1.75e-06	7.53e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.75e-06	7.5e-06	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	1.75e-06	7.5e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.74e-06	7.49e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.74e-06	7.46e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.74e-06	7.46e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	1.72e-06	7.39e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.72e-06	7.38e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.72e-06	7.37e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	1.72e-06	7.37e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.69e-06	7.27e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.68e-06	7.23e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	1.67e-06	7.19e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	1.67e-06	7.16e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.65e-06	7.09e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.65e-06	7.07e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	1.63e-06	7e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	1.62e-06	6.97e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.62e-06	6.97e-06	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.62e-06	6.97e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.61e-06	6.91e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.61e-06	6.9e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.6e-06	6.86e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.59e-06	6.85e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	1.59e-06	6.82e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.56e-06	6.72e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.56e-06	6.71e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.56e-06	6.7e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	1.55e-06	6.65e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	1.54e-06	6.63e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.52e-06	6.54e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.52e-06	6.52e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.52e-06	6.52e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	1.5e-06	6.46e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.5e-06	6.45e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.49e-06	6.41e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.48e-06	6.35e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	6.33e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	1.46e-06	6.28e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.45e-06	6.24e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.44e-06	6.18e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.42e-06	6.09e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.4e-06	6.01e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.4e-06	6e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	5.86e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.36e-06	5.84e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	1.35e-06	5.79e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.32e-06	5.66e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.31e-06	5.64e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.28e-06	5.51e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.25e-06	5.38e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.22e-06	5.24e-06	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	1.18e-06	5.06e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.17e-06	5.02e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.15e-06	4.93e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	1.14e-06	4.88e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—epilepsy syndrome	1.1e-06	4.72e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.04e-06	4.45e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.03e-06	4.41e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	4.39e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-06	4.35e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	9.59e-07	4.12e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	9.44e-07	4.05e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	9.31e-07	4e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	8.7e-07	3.74e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	8.38e-07	3.6e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	7.79e-07	3.35e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	5.14e-07	2.21e-06	CbGpPWpGaD
